Type your tag names separated by a space and hit enter

Letermovir

Kathryn Dzintars, Pharm.D., BCPS
Letermovir is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or purchase a subscription.

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

Johns Hopkins Guides

-- The first section of this topic is shown below --

INDICATIONS

FDA

  • Prophlyaxis of cytomegalovirus infection (CMV) in patients (> 18 years of age) who are CMV-seropositive and have undergone an allogeneic stem cell transplant

-- To view the remaining sections of this topic, please or purchase a subscription --

Last updated: June 6, 2018

Citation

Dzintars, Kathryn. "Letermovir." Johns Hopkins ABX Guide, The Johns Hopkins University, 2018. Johns Hopkins Guide, www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540691/all/Letermovir.
Dzintars K. Letermovir. Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540691/all/Letermovir. Accessed March 22, 2019.
Dzintars, K. (2018). Letermovir. In Johns Hopkins ABX Guide. Available from https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540691/all/Letermovir
Dzintars K. Letermovir [Internet]. In: Johns Hopkins ABX Guide. The Johns Hopkins University; 2018. [cited 2019 March 22]. Available from: https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540691/all/Letermovir.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC T1 - Letermovir ID - 540691 A1 - Dzintars,Kathryn,Pharm.D., BCPS Y1 - 2018/06/06/ BT - Johns Hopkins ABX Guide UR - https://www.hopkinsguides.com/hopkins/view/Johns_Hopkins_ABX_Guide/540691/all/Letermovir PB - The Johns Hopkins University DB - Johns Hopkins Guide DP - Unbound Medicine ER -